Tag: patient advocacy
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-
Announcing the ALK International Development Alliance (IDA)
As part of the ALK Positive mission statement the ALK Positive Inc Board of Directors is committed to assisting ALK patients worldwide. Whilst there are many international members in the independent ALK Facebook Support Group, we are also greatly encouraged by the numerous international patients and caregivers who have subscribed to our newsletter. Amongst other…
-
ALK in the house- IASLC Targeted Therapies Poster Presentation
TITLE: The role of the ALK Positive community in improving outcomes for ALK-positive patients AUTHOR: Dr. Colin Barton DDS Background: Approximately four (4) to seven (7) percent of non-small cell lung cancer (NSCLC) is driven by the ALK transfusion. In the United States, approximately 11,000 people are diagnosed with ALK-positive NSCLC every year. There is…